These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer. Loftsson T. Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564 [Abstract] [Full Text] [Related]
6. Solubility and permeability of steroids in water in the presence of potassium halides. Messner M, Loftsson T. Pharmazie; 2010 Feb; 65(2):83-5. PubMed ID: 20225648 [Abstract] [Full Text] [Related]
7. What determines drug solubility in lipid vehicles: is it predictable? Rane SS, Anderson BD. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):638-56. PubMed ID: 18089295 [Abstract] [Full Text] [Related]
8. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties. Foldvari M, Bagonluri M. Nanomedicine; 2008 Sep 17; 4(3):173-82. PubMed ID: 18550451 [Abstract] [Full Text] [Related]
9. Effects of cyclodextrins on drug delivery through biological membranes. Loftsson T, Vogensen SB, Brewster ME, Konrádsdóttir F. J Pharm Sci; 2007 Oct 17; 96(10):2532-46. PubMed ID: 17630644 [Abstract] [Full Text] [Related]
10. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Brewster ME, Loftsson T. Pharmazie; 2002 Feb 17; 57(2):94-101. PubMed ID: 11878196 [Abstract] [Full Text] [Related]
11. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis. Avdeef A, Kansy M, Bendels S, Tsinman K. Eur J Pharm Sci; 2008 Jan 17; 33(1):29-41. PubMed ID: 17983735 [Abstract] [Full Text] [Related]
12. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Pouton CW, Porter CJ. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):625-37. PubMed ID: 18068260 [Abstract] [Full Text] [Related]
13. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers. Loftsson T. Pharmazie; 1998 Nov 17; 53(11):733-40. PubMed ID: 9853355 [Abstract] [Full Text] [Related]
14. Cyclodextrins in drug delivery. Loftsson T, Jarho P, Másson M, Järvinen T. Expert Opin Drug Deliv; 2005 Mar 17; 2(2):335-51. PubMed ID: 16296758 [Abstract] [Full Text] [Related]
15. Aqueous solubility and true solutions. Loftsson T. Pharmazie; 2010 Jun 17; 65(6):404-7. PubMed ID: 20614686 [Abstract] [Full Text] [Related]
16. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Chen ML. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):768-77. PubMed ID: 18077051 [Abstract] [Full Text] [Related]
17. A technical feasibility study of surfactant-free drug suspensions using octenyl succinate-modified starches. Kuentz M, Egloff P, Röthlisberger D. Eur J Pharm Biopharm; 2006 May 17; 63(1):37-43. PubMed ID: 16356701 [Abstract] [Full Text] [Related]
18. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. O'Driscoll CM, Griffin BT. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):617-24. PubMed ID: 18155800 [Abstract] [Full Text] [Related]